File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Reply to: "Bepirovirsen/GSK3389404: Antisense or TLR9 agonists?"

TitleReply to: "Bepirovirsen/GSK3389404: Antisense or TLR9 agonists?"
Authors
Issue Date22-Feb-2023
PublisherElsevier
Citation
Journal of Hepatology, 2023, v. 78, n. 3, p. E108-E110 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/331853
ISSN
2021 Impact Factor: 30.083
2020 SCImago Journal Rankings: 7.112
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYou, SHY-
dc.contributor.authorElston, R-
dc.contributor.authorYuen, MF-
dc.date.accessioned2023-09-28T04:59:07Z-
dc.date.available2023-09-28T04:59:07Z-
dc.date.issued2023-02-22-
dc.identifier.citationJournal of Hepatology, 2023, v. 78, n. 3, p. E108-E110-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/331853-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofJournal of Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleReply to: "Bepirovirsen/GSK3389404: Antisense or TLR9 agonists?"-
dc.typeArticle-
dc.identifier.doi10.1016/j.jhep.2022.11.023-
dc.identifier.pmid36460165-
dc.identifier.scopuseid_2-s2.0-85148772964-
dc.identifier.volume78-
dc.identifier.issue3-
dc.identifier.spageE108-
dc.identifier.epageE110-
dc.identifier.isiWOS:000953988300001-
dc.publisher.placeAMSTERDAM-
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats